Skip to Main content Skip to Navigation
Journal articles

Optimizing Conventional Medical Therapies in Inflammatory Bowel Disease in 2014

Abstract : Goals of therapy for inflammatory bowel disease have advanced beyond symptom control to the normalization of biomarkers of inflammation, and mucosal healing in particular, with the expectation that this will change the natural history of these diseases. Concurrent with higher treatment expectations has come an expanded therapeutic armamentarium to achieve these goals, and a greater ability to optimize each therapeutic class to maximize therapeutic benefits and minimize unnecessary treatment failures. In addition to these advances has come the evolution of therapeutic drug monitoring which is increasingly being utilized to optimize the use of immunomodulators and biologic therapies in particular. This review will outline the principals of optimization of the conventional medical therapies available to the clinician today.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-lorraine.fr/hal-01691119
Contributor : Ngere Ul <>
Submitted on : Tuesday, January 23, 2018 - 4:30:35 PM
Last modification on : Tuesday, October 13, 2020 - 10:47:15 AM

Identifiers

  • HAL Id : hal-01691119, version 1
  • PUBMED : 25219568

Collections

Citation

Anil Kumar Asthana, Miles Sparrow, Laurent Peyrin-Biroulet. Optimizing Conventional Medical Therapies in Inflammatory Bowel Disease in 2014 . Current Drug Targets, Bentham Science Publishers, 2014, 15 (11), pp.1002-1010. ⟨hal-01691119⟩

Share

Metrics

Record views

80